Gleneagles Hospital Hong Kong marked the beginning of its local antimicrobial resistance (AMR) programme with a pledge to promote the responsible use of antibiotics and help raise public awareness of AMR.
Led by its CEO Dr Kenneth Tsang, the hospital departments showed their support by pledging to use antibiotics responsibly.
As part of IHH’s sustainability commitment to Care for Public, all IHH hospitals will implement antimicrobial resistance interventions in line with CDC, WHO and national guidelines by 2025.
Related Stories
Turning Clinical Insights into Better Patient Outcomes
.jpg?sfvrsn=745604e1_1)
Gleneagles Hong Kong Leads the Way in Advancing Liver Cancer Care
Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
55fda2dc551e4ff68748a1aabe8694a6.jpg?sfvrsn=a1e3ed8c_1)
Parkway East Hospital Supports Healthy Ageing with Its New Live Well Centre and Sleep Laboratory
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
